Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rosa-Maria Espadero"'
Autor:
Peter Schmid, Marie-Paule Sablin, Jonas Bergh, Seock-Ah Im, Yen-Shen Lu, Noelia Martínez, Patrick Neven, Keun Seok Lee, Serafín Morales, J. Alejandro Pérez-Fidalgo, Douglas Adamson, Anthony Gonçalves, Aleix Prat, Guy Jerusalem, Laura Schlieker, Rosa-Maria Espadero, Thomas Bogenrieder, Dennis Chin-Lun Huang, John Crown, Javier Cortés
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Abstract Background Xentuzumab—a humanised IgG1 monoclonal antibody—binds IGF-1 and IGF-2, inhibiting their growth-promoting signalling and suppressing AKT activation by everolimus. This phase Ib/II exploratory trial evaluated xentuzumab plus eve
Externí odkaz:
https://doaj.org/article/1117dc67dd994a8f8f4c31719c73a41f
Autor:
Seock-Ah Im, Patrick Neven, John Crown, Rosa-Maria Espadero, Noelia Martínez, Yen-Shen Lu, Jonas Bergh, Thomas Bogenrieder, J. Alejandro Pérez-Fidalgo, Peter Schmid, Guy Jerusalem, Laura Schlieker, Serafin Morales, Dennis Chin-Lun Huang, Douglas Adamson, Javier Cortes, Anthony Gonçalves, Keun Seok Lee, Marie-Paule Sablin, Aleix Prat
Publikováno v:
Breast Cancer Research
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientia
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientia
Background Xentuzumab—a humanised IgG1 monoclonal antibody—binds IGF-1 and IGF-2, inhibiting their growth-promoting signalling and suppressing AKT activation by everolimus. This phase Ib/II exploratory trial evaluated xentuzumab plus everolimus a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3fb312f1fe2cc964111c140ba48f774
https://hal.science/hal-03630009
https://hal.science/hal-03630009
Autor:
Schmid, Peter, Marie-Paule Sablin, Bergh, Jonas, Seock-Ah Im, Yen-Shen Lu, Martínez, Noelia, Neven, Patrick, Lee, Keun Seok, Serafín Morales, J. Alejandro Pérez-Fidalgo, Adamson, Douglas, Gonçalves, Anthony, Aleix Prat, Jerusalem, Guy, Schlieker, Laura, Rosa-Maria Espadero, Bogenrieder, Thomas, Huang, Dennis Chin-Lun, Crown, John, Cortés, Javier
Additional file 1. : Supplementary material. Supplementary methods, tables and figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0aec8ba26a8bb0d2e8300b1e1954539
Autor:
Langslet, Gisle, Zinman, Bernard, Wanner, Christoph, Hantel, Stefan, Rosa-Maria Espadero, Fitchett, David, Johansen, Odd Erik
Supplemental material, sj-pdf-1-dvr-10.1177_1479164120975256 for Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME® by Gisle Langslet, Bernard Zinman, Christoph Wanner, Stefan Hantel, Rosa-Maria Espadero, David Fitchett and Odd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::603725a483b96def645ffb99fe08a221
Autor:
Rosa-Maria Espadero, Bernard Zinman, David Fitchett, Christoph Wanner, Gisle Langslet, Stefan Hantel, Odd Erik Johansen
Publikováno v:
Diabetes & Vascular Disease Research
Objective: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-choleste
Autor:
Bernard Zinman, David Fitchett, Rosa-Maria Espadero, Stefan Hantel, Uli C. Broedl, Christoph Wanner, Hans-Juergen Woerle, Roberto Ferrari, Odd Erik Johansen, Silvio E. Inzucchi
Publikováno v:
Diabetes & Vascular Disease Research
Given the multi-faceted pathogenesis of atherosclerosis in type 2 diabetes mellitus (T2DM), it is likely that interventions to mitigate this risk must address cardiovascular (CV) risk factors beyond glucose itself. Sodium glucose cotransporter-2 (SGL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ecac04a5502be8656d68101e1655f9
http://hdl.handle.net/11392/2343805
http://hdl.handle.net/11392/2343805
Autor:
Bernard Zinman, Stefan Hantel, Gisle Langslet, David Fitchett, Christoph Wanner, Rosa-Maria Espadero, Odd Erik Johansen, Dae Wook Lee
Publikováno v:
Journal of Hypertension. 34:e518